Biotech executives, investors, and R&D leaders all face the same burning question in 2026: How do we scale breakthroughs from ...

The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...

Commissioned by Zhen-Ao Group, Peking University spent 20 years achieving a full-chain breakthrough in 5'-nucleotide anti-aging research, building a comprehensive evidence-based system spanning ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

The EIC has announced €118 million in funding for 30 research projects under its 2025 EIC Pathfinder Challenges call ...

A Türkiye-originated oncology drug candidate, RS-0139, has successfully completed its Phase 1 clinical trial, positioning itself as a key milestone in ...

Antibiotic resistance is tightening its grip on global healthcare, but the pipeline of truly new treatments remains thin.

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

Connecticut Innovations (CI), the state's strategic venture capital arm, in collaboration with Mission BioCapital (MBC), ...

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...